rs113488022 in BRAF gene and Glioblastoma

PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.

rs55705857 in CCDC26 gene and Glioblastoma

PMID 30152087 2018 Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age.

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

rs145929329 in CDKN2B-AS1 gene and Glioblastoma

PMID 26424050 2015 Genome-wide association study identifies multiple susceptibility loci for glioma.

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

PMID 30152087 2018 Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age.

rs1057519884 in CREBBP gene and Glioblastoma

PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.

rs1057519887 in EGFR gene and Glioblastoma

PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.

PMID 30152087 2018 Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age.

PMID 26424050 2015 Genome-wide association study identifies multiple susceptibility loci for glioma.

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

rs747241612 in FBXW7 gene and Glioblastoma

PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.

rs1057519897 in FGFR1 gene and Glioblastoma

PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.

rs1057519902 in H3-3A gene and Glioblastoma

PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.

rs10852606 in HEATR3 gene and Glioblastoma

PMID 28346443 2017 We identified five new loci for glioblastoma (GBM) at 1p31.3 (rs12752552; P = 2.04 × 10^-9, odds ratio (OR) = 1.22), 11q14.1 (rs11233250; P = 9.95 × 10^-10, OR = 1.24), 16p13.3 (rs2562152; P = 1.93 × 10^-8, OR = 1.21), 16q12.1 (rs10852606; P = 1.29 × 10^-11, OR = 1.18) and 22q13.1 (rs2235573; P = 1.76 × 10^-10, OR = 1.15), as well as eight loci for non-GBM tumors at 1q32.1 (rs4252707; P = 3.34 × 10^-9, OR = 1.19), 1q44 (rs12076373; P = 2.63 × 10^-10, OR = 1.23), 2q33.3 (rs7572263; P = 2.18 × 10^-10, OR = 1.20), 3p14.1 (rs11706832; P = 7.66 × 10^-9, OR = 1.15), 10q24.33 (rs11598018; P = 3.39 × 10^-8, OR = 1.14), 11q21 (rs7107785; P = 3.87 × 10^-10, OR = 1.16), 14q12 (rs10131032; P = 5.07 × 10^-11, OR = 1.33) and 16p13.3 (rs3751667; P = 2.61 × 10^-9, OR = 1.18).

rs104894230 in HRAS;LRRC56 gene and Glioblastoma

PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.

rs121913499 in IDH1 gene and Glioblastoma

PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.

rs104894229 in LRRC56;HRAS gene and Glioblastoma

PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.

rs11233250 in MIR4300HG gene and Glioblastoma

PMID 28346443 2017 We identified five new loci for glioblastoma (GBM) at 1p31.3 (rs12752552; P = 2.04 × 10^-9, odds ratio (OR) = 1.22), 11q14.1 (rs11233250; P = 9.95 × 10^-10, OR = 1.24), 16p13.3 (rs2562152; P = 1.93 × 10^-8, OR = 1.21), 16q12.1 (rs10852606; P = 1.29 × 10^-11, OR = 1.18) and 22q13.1 (rs2235573; P = 1.76 × 10^-10, OR = 1.15), as well as eight loci for non-GBM tumors at 1q32.1 (rs4252707; P = 3.34 × 10^-9, OR = 1.19), 1q44 (rs12076373; P = 2.63 × 10^-10, OR = 1.23), 2q33.3 (rs7572263; P = 2.18 × 10^-10, OR = 1.20), 3p14.1 (rs11706832; P = 7.66 × 10^-9, OR = 1.15), 10q24.33 (rs11598018; P = 3.39 × 10^-8, OR = 1.14), 11q21 (rs7107785; P = 3.87 × 10^-10, OR = 1.16), 14q12 (rs10131032; P = 5.07 × 10^-11, OR = 1.33) and 16p13.3 (rs3751667; P = 2.61 × 10^-9, OR = 1.18).

rs1057519913 in MTOR gene and Glioblastoma

PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.

rs1057519919 in MYCNOS;MYCN gene and Glioblastoma

PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.

rs11554290 in NRAS gene and Glioblastoma

PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.

rs104886003 in PIK3CA gene and Glioblastoma

PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.

rs1057519757 in PIK3R1 gene and Glioblastoma

PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.

rs1057519945 in POLE gene and Glioblastoma

PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.

rs3851634 in POLR3B gene and Glioblastoma

PMID 26424050 2015 After genotyping an additional 1,490 cases and 1,723 controls we identify new risk loci for glioblastoma (GBM) at 12q23.33 (rs3851634, near POLR3B, P=3.02 × 10(-9)) and non-GBM at 10q25.2 (rs11196067, near VTI1A, P=4.32 × 10(-8)), 11q23.2 (rs648044, near ZBTB16, P=6.26 × 10(-11)), 12q21.2 (rs12230172, P=7.53 × 10(-11)) and 15q24.2 (rs1801591, near ETFA, P=5.71 × 10(-9)).

rs121909224 in PTEN gene and Glioblastoma

PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.

rs12752552 in RAVER2 gene and Glioblastoma

PMID 28346443 2017 We identified five new loci for glioblastoma (GBM) at 1p31.3 (rs12752552; P = 2.04 × 10^-9, odds ratio (OR) = 1.22), 11q14.1 (rs11233250; P = 9.95 × 10^-10, OR = 1.24), 16p13.3 (rs2562152; P = 1.93 × 10^-8, OR = 1.21), 16q12.1 (rs10852606; P = 1.29 × 10^-11, OR = 1.18) and 22q13.1 (rs2235573; P = 1.76 × 10^-10, OR = 1.15), as well as eight loci for non-GBM tumors at 1q32.1 (rs4252707; P = 3.34 × 10^-9, OR = 1.19), 1q44 (rs12076373; P = 2.63 × 10^-10, OR = 1.23), 2q33.3 (rs7572263; P = 2.18 × 10^-10, OR = 1.20), 3p14.1 (rs11706832; P = 7.66 × 10^-9, OR = 1.15), 10q24.33 (rs11598018; P = 3.39 × 10^-8, OR = 1.14), 11q21 (rs7107785; P = 3.87 × 10^-10, OR = 1.16), 14q12 (rs10131032; P = 5.07 × 10^-11, OR = 1.33) and 16p13.3 (rs3751667; P = 2.61 × 10^-9, OR = 1.18).

rs2562152 in RHBDF1 gene and Glioblastoma

PMID 28346443 2017 We identified five new loci for glioblastoma (GBM) at 1p31.3 (rs12752552; P = 2.04 × 10^-9, odds ratio (OR) = 1.22), 11q14.1 (rs11233250; P = 9.95 × 10^-10, OR = 1.24), 16p13.3 (rs2562152; P = 1.93 × 10^-8, OR = 1.21), 16q12.1 (rs10852606; P = 1.29 × 10^-11, OR = 1.18) and 22q13.1 (rs2235573; P = 1.76 × 10^-10, OR = 1.15), as well as eight loci for non-GBM tumors at 1q32.1 (rs4252707; P = 3.34 × 10^-9, OR = 1.19), 1q44 (rs12076373; P = 2.63 × 10^-10, OR = 1.23), 2q33.3 (rs7572263; P = 2.18 × 10^-10, OR = 1.20), 3p14.1 (rs11706832; P = 7.66 × 10^-9, OR = 1.15), 10q24.33 (rs11598018; P = 3.39 × 10^-8, OR = 1.14), 11q21 (rs7107785; P = 3.87 × 10^-10, OR = 1.16), 14q12 (rs10131032; P = 5.07 × 10^-11, OR = 1.33) and 16p13.3 (rs3751667; P = 2.61 × 10^-9, OR = 1.18).

rs2297440 in RTEL1;RTEL1-TNFRSF6B gene and Glioblastoma

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

PMID 30152087 2018 Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age.

PMID 26424050 2015 Genome-wide association study identifies multiple susceptibility loci for glioma.

rs2235573 in SLC16A8 gene and Glioblastoma

PMID 28346443 2017 We identified five new loci for glioblastoma (GBM) at 1p31.3 (rs12752552; P = 2.04 × 10^-9, odds ratio (OR) = 1.22), 11q14.1 (rs11233250; P = 9.95 × 10^-10, OR = 1.24), 16p13.3 (rs2562152; P = 1.93 × 10^-8, OR = 1.21), 16q12.1 (rs10852606; P = 1.29 × 10^-11, OR = 1.18) and 22q13.1 (rs2235573; P = 1.76 × 10^-10, OR = 1.15), as well as eight loci for non-GBM tumors at 1q32.1 (rs4252707; P = 3.34 × 10^-9, OR = 1.19), 1q44 (rs12076373; P = 2.63 × 10^-10, OR = 1.23), 2q33.3 (rs7572263; P = 2.18 × 10^-10, OR = 1.20), 3p14.1 (rs11706832; P = 7.66 × 10^-9, OR = 1.15), 10q24.33 (rs11598018; P = 3.39 × 10^-8, OR = 1.14), 11q21 (rs7107785; P = 3.87 × 10^-10, OR = 1.16), 14q12 (rs10131032; P = 5.07 × 10^-11, OR = 1.33) and 16p13.3 (rs3751667; P = 2.61 × 10^-9, OR = 1.18).

rs7732320 in SSBP2 gene and Glioblastoma

PMID 22472174 2012 SSBP2 variants are associated with survival in glioblastoma patients.

rs10069690 in TERT gene and Glioblastoma

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

PMID 30152087 2018 Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age.

PMID 26424050 2015 Genome-wide association study identifies multiple susceptibility loci for glioma.

rs1057519981 in TP53 gene and Glioblastoma

PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.

PMID 26424050 2015 Genome-wide association study identifies multiple susceptibility loci for glioma.

PMID 30152087 2018 Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age.

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.